Sodium–glucose co‐transporter 2 inhibition with empagliflozin improves cardiac function in non‐diabetic rats with left ventricular dysfunction after myocardial infarction
2019 ◽
Vol 21
(7)
◽
pp. 862-873
◽
2020 ◽
Vol 34
(3)
◽
pp. 311-321
◽
1996 ◽
Vol 78
(2)
◽
pp. 158-162
◽
2006 ◽
Vol 5
(1)
◽
pp. 181-182
2008 ◽
Vol 7
◽
pp. 113-113
1998 ◽
Vol 31
(2)
◽
pp. 490A
2017 ◽
Vol 6
(7)
◽
1984 ◽
Vol 4
(5)
◽
pp. 867-874
◽